This Biotech Had Positive Data In Gene Therapy — But It Wasn't Enough

·

·

This Biotech Had Positive Data In Gene Therapy — But It Wasn't Enough

BioMarin Pharmaceutical stock dipped Tuesday after its gene therapy results underwhelmed investors and raised “more questions” regarding hemophilia A treatment. X. In early trading on the stock market today, shares of BioMarin (BMRN) slipped 2.1%, near …
See Original Article

Beyond Meat opens first production plant outside US

EL SEGUNDO, Calif. — Plant-based meat company Beyond Meat is opening its first production facility outside the U.S.. The El Segundo, California-based company is partnering with Dutch meat producer Zandbergen World’s Finest Meat. Zandbergen will …
See Original Article

Roku's 200% surge this year has made the stock too expensive, analyst says

Roku has tripled in value this year, outperforming almost every notable technology stock, and Kyle Evans of investment bank Stephens says the rally has finally gone too far. Evans downgraded his rating on Roku to “equalweight” from “overweight,” citing too …
See Original Article

IBM-Maersk blockchain shipping consortium expands to include other major shipping companies

Last year IBM and Danish shipping conglomerate Maersk announced the limited availability of a blockchain-based shipping tool called TradeLens. Today, the two partners announced that a couple of other major shippers have come on board. The partners …
See Original Article

Leading the pack, again

An established industry study shows that American Express customers in Singapore are the most satisfied for the fourth year running. For the fourth straight year, American Express topped up an industry-leading survey on credit card satisfaction among …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.